Feb. 21, 2025
The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

Celerian Group Company Administrators, LLC, Noridian Healthcare Solutions, LLC, and Palmetto GBA released final local coverage determinations (LCDs) about Minimally Invasive Arthrodesis of the Sacroiliac Joint that say, “Minimally Invasive (MI) Arthrodesis of the sacroiliac joint (SIJ) WITHOUT placement of a transfixation device is NOT considered medically reasonable and necessary.”

The College and specialty societies urge the MACs to withdraw these LCDs before April 17, when they are scheduled to take effect, and be given the opportunity to update them related to nuances in Current Procedural Terminology (CPT) codes 27278 and 27279 and reporting practices. The ACR Contractor Advisory Committee Network representatives continue to monitor local coverage activities and address concerns that will adversely impact the interventional radiology community.  

For more information about local coverage determination activities or questions, contact Alicia Blakey, ACR Principal Economic Policy Analyst.

Related ACR News

  • Capitol Hill Day May 7 Offers Direct Voice With Congress

    ACR 2025 attendees will have the opportunity to meet with members of Congress and congressional staff May 7, during the College’s Capitol Hill Day in Washington.

    Read more
  • National Correct Coding Initiative Quarterly Updates Released

    CMS released quarterly National Correct Coding Initiative Procedure-to-Procedure, Medically Unlikely Edits and Add-on Code edits that take effect July 1.

    Read more
  • CMS Extends MIPS Submission Deadline

    CMS announced that the Extreme and Uncontrollable Circumstances application for clinicians participating in the 2024 MIPS will be reopened due to the ongoing national IV fluid shortage.

    Read more